$ATNF News
Last published 1y ago
- 1y agoATNF180 Life Sciences (ETHZilla) Holds 82,186 ETHPR Newswire180 Life Sciences Corp. (Nasdaq: ATNF), dba ETHZilla (the "Company", "180 Life Sciences" or "ETHZilla"), announced today that is has total holdings...
- 1y agoATNF180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible NotesPR Newswire180 Life Sciences Corp. (Nasdaq: ATNF), (the "Company" or "ETHZilla"), today announced that it has sold approximately $156 million aggregate...
- 1y agoATNF180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury StrategyPR Newswire180 Life Sciences Corp. (Nasdaq: ATNF), (the "Company" or "ETHZilla"), has closed its previously announced private placement, raising $425 million in ...
- 1y agoATNF180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZillaPR Newswire180 Life Sciences Corp. (Nasdaq: ATNF) (the "Company" or "180 Life Sciences") today announced that it plans to adopt a treasury policy under which...
- 1y agoATNF180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property AssetsACCESS NewswirePALO ALTO, CA / ACCESS Newswire / July 1, 2025 / 180 Life Sciences Corp. , an innovative biotechnology company that is currently pivoting to the global iGaming sector,
- 1y agoATNF180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive DysfunctionACCESS NewswirePALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. , an innovative media and entertainment company focused on the global
- 1y agoATNF180 Life Sciences Corp. Announces Share RepurchaseACCESS NewswirePALO ALTO, CALIFORNIA / ACCESS Newswire / April 30, 2025 / 180 Life Sciences Corp. today announced that it has
- 1y agoATNF180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ RulesACCESS NewswirePALO ALTO, CA / ACCESSWIRE / December 27, 2024 / 180 Life Sciences Corp. , a biotechnology company that is currently refocusing its business on the international
- 1y agoATNF180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing RulesACCESS NewswirePALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605, which
- 1y agoATNF180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of DirectorsACCESS NewswirePALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. , a biotechnology company that is currently refocusing its business on the international
- 2y agoATNF180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform IntegrationACCESS NewswirePALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. today announced the retention of Mr. Vaclav Vincalek as Senior Technology Consultant. An
- 2y agoATNF180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of DirectorsACCESS NewswirePALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective
- 2y agoATNFELRAElray Resources Announces Strategic Sale of Crypto iGaming TechnologyGlobeNewswireLAS VEGAS, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Elray Resources Inc. (OTCPK:ELRA) is pleased to announce a significant milestone in the company's growth strategy. Elray has completed the sale of proprietary technology
- 2y agoATNF180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology PlatformACCESS NewswirePALO ALTO, CA / ACCESSWIRE / October 16, 2024 / 180 Life Sciences Corp. , today released the following letter to stockholders from its Interim Chief Executive
- 2y agoATNF180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming SectorACCESS NewswirePALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. , is pleased to announce that it has received confirmation from Nasdaq that the Company has
- 2y agoATNF180 Life Sciences Corp. - Corporate UpdatesACCESS NewswireAnnouncing Acquisition of Advanced Gaming Technology Platform, Positive Progress on Legacy CBD Formulation, and Strengthened Balance SheetPALO ALTO, CA / ACCESSWIRE / October 3, 2024 / 180 Life Sciences Corp.
- 2y agoATNF180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial OfficerGlobeNewswirePALO ALTO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce the appointment of Omar Jimenez as its new Chief Financial Officer, effective September 30,
- 2y agoATNF180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral UptakeGlobeNewswirePALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced topline results
- 2y agoATNF180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing RequirementsGlobeNewswirePALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that it received notice from the Nasdaq Listing Qualifications Panel
- 2y agoATNF180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing RequirementsGlobeNewswirePALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that it received notice from the Nasdaq Listing Qualifications Panel
- 2y agoATNF180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswirePALO ALTO, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the Company received a letter on March 13, 2024 from The Nasdaq
- 2y agoATNF180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance PlanGlobeNewswirePALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares of
- 2y agoATNF180 Life Sciences Engages Financial Advisor to Explore Strategic AlternativesGlobeNewswirePALO ALTO, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced it has engaged A.G.P./Alliance Global Partners as financial advisor to
- 2y agoATNF180 Life Sciences Announces Review of Strategic AlternativesGlobeNewswirePALO ALTO, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that its Board of Directors has initiated a process to evaluate
- 3y agoATNF180 Life Sciences Corp. Announces Closing of $3 Million Public OfferingGlobeNewswirePALO ALTO, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF, "180 Life Sciences" or the "Company")), a clinical-stage biotechnology company, today announced the closing of its previously
- 3y agoATNF180 Life Sciences Corp. Announces Pricing of $3 Million Public OfferingGlobeNewswirePALO ALTO, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF, "180 Life Sciences" or the "Company")), a clinical-stage biotechnology company, today announced the pricing of a public
- 3y agoATNF180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral UptakeGlobeNewswirePALO ALTO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that an agreement has been reached with Prof. Avi Domb of the Hebrew
- 3y agoATNF180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren's Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDAGlobeNewswirePALO ALTO, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that
- 3y agoATNF180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress AppetiteGlobeNewswirePALO ALTO, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180LS" or the "Company"), today announced the filing of a provisional patent describing the novel combination of CBD, or an
- 3y agoATNF180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private PlacementGlobeNewswirePALO ALTO, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF, "180 Life Sciences" or the "Company")), a clinical-stage biotechnology company, today announced the closing of its previously
- 3y agoATNF180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private PlacementGlobeNewswirePALO ALTO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF, "180 Life Sciences" or the "Company")), a clinical-stage biotechnology company, today announced that it has entered into a
- 3y agoATNFElicit Plant Appoints Pam Marrone and Johan de Saegher on Its Board of DirectorsBusiness WirePam Marrone joins as Chairwoman of the Board of Directors and Johan de Saegher as Independent Board Member Elicit Plant, an agricultural biotechnology company specialized in crops' resistance to water stress based on
- 3y agoATNF180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren's Disease Treatment and ApplicationGlobeNewswirePALO ALTO, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the United States Patent and Trademark Office (USPTO) has issued
- 3y agoATNF180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder TrialGlobeNewswirePALO ALTO, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced closure to recruitment of men and women across England with early stage
- 3y agoATNF180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren's DiseaseGlobeNewswirePALO ALTO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced the publication of a review entitled ‘Treatments for early stage
- 3y agoATNF180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United KingdomGlobeNewswirePALO ALTO, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the Company has engaged Kinexum, a strategic advisory firm, to
- 3y agoATNFNewman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)Business WireNewman Ferrara LLP announced today that it has an ongoing investigation into actions taken by officers and directors of KBL Merger Corp. IV ("KBL"), a special purpose acquisition company ("SPAC") in connection to its
- 3y agoATNF180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswirePALO ALTO, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the Company received a letter on January 4, 2023 from The Nasdaq
- 3y agoATNF180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren's DiseaseGlobeNewswirePALO ALTO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced the publication of a review entitled ‘Dupuytren's disease: a localized
- 3y agoATNF180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to ShareholdersGlobeNewswirePALO ALTO, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Dear Fellow Shareholder, As we come to the end of 2022, I am pleased to provide an update for our shareholders. In keeping with good corporate practice and US
- 3y agoATNF180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewswirePALO ALTO, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF, "180 Life Sciences" or the "Company")), a clinical-stage biotechnology company, today announced the closing of its previously
- 3y agoATNF180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewswirePALO ALTO, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF, "180 Life Sciences" or the "Company")), a clinical-stage biotechnology company, today announced that it has entered into a
- 3y agoATNF180 Life Sciences Corp. Announces 1-for 20 Reverse Stock Split as Part of Nasdaq Compliance PlanGlobeNewswirePALO ALTO, Calif., Dec. 16, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that it will effect a one-for-20 reverse stock split ("reverse split")
- 3y agoATNF180 Life Sciences Provides Update on Progress To Seek Medicines and Healthcare Products Regulatory Agency Marketing Authorization for Anti-TNF Treatment of Early Stage Dupuytren's ContractureGlobeNewswirePALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the Company and its regulatory consultants from the US and the UK,
- 3y agoATNF180 Life Sciences to Participate in A.G.P.'s Virtual Biotech Conference to be Held November 30 – December 1, 2022GlobeNewswirePALO ALTO, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that
- 3y agoATNFAdalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytren's DiseaseGlobeNewswirePALO ALTO, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company today announced that researchers at Oxford
- 4y agoATNF180 Life Sciences Issues Letter to StockholdersGlobeNewswirePALO ALTO, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company today released the following letter to stockholders from its Chief Executive Offi
- 4y agoATNF180 Life Sciences with the University of Oxford Announce the Enrollment of the First Patient in a Trial of Anti-TNF for People with Early-Stage Frozen ShoulderGlobeNewswirePALO ALTO, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company announced that the first patient has been randomized in the clinical trial to eval
- 4y agoATNF180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program With 180 Life Sciences Corp.GlobeNewswirePALO ALTO, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company, today announced that a team led by researchers at University of Oxford have been
- 4y agoATNF180 Life Sciences Corp. Announces Closing of $6.5 Million Registered Direct OfferingGlobeNewswirePALO ALTO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF, "180 Life Sciences" or the "Company"))), a clinical-stage biotechnology company, today announced the closing of its previously-announced registered direct offeri